WEKO3
アイテム
Effect of Valsartan, an Angiotensin-II-Receptor Antagonist, on Left Ventricular Hypertrophy in Type 2 Diabetic Patients
http://hdl.handle.net/10191/1919
http://hdl.handle.net/10191/1919d39e3ace-45ed-43e9-b262-08eeafe6b8f9
| 名前 / ファイル | ライセンス | アクション |
|---|---|---|
KJ00000007374.pdf (7.4 MB)
|
|
| Item type | 紀要論文 / Departmental Bulletin Paper(1) | |||||
|---|---|---|---|---|---|---|
| 公開日 | 2007-05-10 | |||||
| タイトル | ||||||
| タイトル | Effect of Valsartan, an Angiotensin-II-Receptor Antagonist, on Left Ventricular Hypertrophy in Type 2 Diabetic Patients | |||||
| タイトル | ||||||
| タイトル | Effect of Valsartan, an Angiotensin-II-Receptor Antagonist, on Left Ventricular Hypertrophy in Type 2 Diabetic Patients | |||||
| 言語 | en | |||||
| 言語 | ||||||
| 言語 | eng | |||||
| キーワード | ||||||
| 主題Scheme | Other | |||||
| 主題 | left ventricular hypertrophy | |||||
| キーワード | ||||||
| 主題Scheme | Other | |||||
| 主題 | valsartan | |||||
| キーワード | ||||||
| 主題Scheme | Other | |||||
| 主題 | Type 2 diabetes mellitus | |||||
| 資源タイプ | ||||||
| 資源 | http://purl.org/coar/resource_type/c_6501 | |||||
| タイプ | departmental bulletin paper | |||||
| 著者 |
SUZUKI, Katsunori
× SUZUKI, Katsunori× KATO, Kiminori× SOUDA, Satoshi× AIZAWA, Yoshifusa |
|||||
| 抄録 | ||||||
| 内容記述タイプ | Abstract | |||||
| 内容記述 | Background: The aim of the present study was to examine the effects of an angiotensin-II-receptor antagonist, valsartan, on echocardiographically proven left ventricular hypertrophy in patients with Type 2 diabetes. Methods: Patients received a low dose of valsartan for 6 months. This low dose has no clinical effect on blood pressure. Echocardiographic data of 37 patients were analyzed. Results: After 6 months of valsartan therapy, the overall mean left ventricular mass index decreased slightly, from 109.0±26.1 to 108.1±22.0 g/m^2 (n=37). However a significant decrease was observed in the subgroup of patients with LVH (n=16), from 128.3±22.9 to 121.9±23.3 g/m^2 (P<0.05). There were no significant differences before and after treatment in body mass index, HbA_<1c>, or systolic or diastolic blood pressure. Conclusion: In Type 2 diabetic patients with left ventricular hypertrophy, treatment with valsartan for 6 months reduced the left ventricular mass index with no fall in systemic blood pressure. | |||||
| 書誌情報 |
Acta medica et biologica en : Acta medica et biologica 巻 51, 号 3, p. 79-85, 発行日 2003-09 |
|||||
| 出版者 | ||||||
| 出版者 | Niigata University School of Medicine | |||||
| ISSN | ||||||
| 収録物識別子タイプ | ISSN | |||||
| 収録物識別子 | 05677734 | |||||
| 書誌レコードID | ||||||
| 収録物識別子タイプ | NCID | |||||
| 収録物識別子 | AA00508361 | |||||
| 著者版フラグ | ||||||
| 値 | publisher | |||||
